← Back to Search

Other

Low FODMAP Diet for Irritable Bowel Syndrome

N/A
Waitlist Available
Led By Judy Nee, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
aged 18-65 years at the time of screening
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how diet can help symptoms of IBS-D. It looks at how a diet low in FODMAPs can reduce symptoms.

Who is the study for?
This trial is for adults aged 18-65 with Irritable Bowel Syndrome (IBS), specifically those who often have diarrhea. Participants must have normal blood and stool test results, no C diff infections or parasites, and a certain score on an IBS symptom severity scale.
What is being tested?
The study is testing the effects of a Low FODMAP Diet (LFD) on patients with IBS. The LFD aims to reduce symptoms by limiting foods that are high in certain sugars which can be hard to digest and may cause gut discomfort.
What are the potential side effects?
While not explicitly stated, potential side effects of the Low FODMAP Diet may include changes in diet satisfaction, nutritional deficiencies if not properly managed, and possible alterations in gut microbiota.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
colonic permeability
Secondary study objectives
colonic immune cells
colonic microbiome

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: FODMAP dietExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
855 Previous Clinical Trials
12,930,921 Total Patients Enrolled
8 Trials studying Irritable Bowel Syndrome
865 Patients Enrolled for Irritable Bowel Syndrome
University of MichiganOTHER
1,853 Previous Clinical Trials
6,432,985 Total Patients Enrolled
13 Trials studying Irritable Bowel Syndrome
933 Patients Enrolled for Irritable Bowel Syndrome
Judy Nee, MDPrincipal InvestigatorBeth Israel Deaconess Medical Center
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top